]>
IRCT20200418047119N1 IRCT 2020-09-01 Kermanshah University of Medical Sciences Effect of curcumin in treatment of respiratory syndrome of corona Evaluation the effectiveness of curcumin in the treatment of patients with covid-19 sever acute respiratory syndrome 2020-08-31 anticipated 42 Complete https://irct.ir/trial/47231 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomly assigned to two groups of block classes and randomization perform using random function of excel. The type of treatment received, the size of the block and the randomization process will be kept secret from the patient and the lead researcher of the study and the person who will make the final assessment, Blinding description: Participants, the main researcher, health care staffs including physicians and nurses who are responsible for patient care, data collection officials, and those who evaluate the outcome are kept blind. 2-3 Covid-19. Intervention 1: Intervention group: Patients with acute respiratory syndrome of corona who are supposed to receive curcumin daily in addition to the usual medications, so that they take three of the 50 mg curcumin capsules made by Dineh Company for 7 days every 8 hours. Intervention 2: Control group: Patients with acute respiratory syndrome of corona who are treated only with usual medications and do not receive curcumin. Yes - There is a plan to make this available What will be shared: The results of the study and the collected data will be published in the form of an article When: After the paper is published To whom: All clinical researchers Conditions: The data can only be used for review studies or to find a cure for an epidemic. Where to obtain: Dr Sajad Moradi from Kermanshah University of Medical Sciences, send request by sajadmoradi28@gmail.com How to obtain: The data will finally reach the applicant one week after the request Comments:
public Sajad Moradi
Parastar Blvd
Kermanshah Iran (Islamic Republic of) 6714415153 0988334276489 sajadmoradi28@gmail.com Kermanshah University of Medical Sciences scientific Sajad Moradi
Parastar Blvd
Kermanshah Iran (Islamic Republic of) 6714415153 +98 83 3427 6489 sajadmoradi28@gmail.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) All people with acute respiratory syndrome of corona no limit no limit Both Patients with high risk or patients with acute respiratory conditions who enter the ICU from the beginning U07.1 Covid-19 disease Treatment - Drugs Treatment - Drugs Intervention group: Patients with acute respiratory syndrome of corona who are supposed to receive curcumin daily in addition to the usual medications, so that they take three of the 50 mg curcumin capsules made by Dineh Company for 7 days every 8 hours. Control group: Patients with acute respiratory syndrome of corona who are treated only with usual medications and do not receive curcumin. Body temperature. Timepoint: Body temperature is measured at the beginning of the study, on the third and seventh days. Method of measurement: Thermometer. Oxygen saturation. Timepoint: The percentage of oxygen saturation is measured at the beginning of the study, on the third and seventh days. Method of measurement: Oxymeter. Lung inflammation observed with CT scan. Timepoint: The CT scan image is taken at the beginning of the study and on the third and seventh days. Method of measurement: CT-scan imaging. Kermanshah University of Medical Sciences Approved 2020-03-02 Ethics committee of Kermanshah University of Medical Sciences Shahid Beheshti Blvd Kermanshah Kermanshah Iran (Islamic Republic of)